This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Tattevin, P. Articles by Michelet, C. Search for Related Content PubMed PubMed Citation Articles by Tattevin, P. Articles by Michelet, C.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, May 2006, p. 1873-1874, Vol. 44, No. 5
0095-1137/06/$08.00+0     doi:10.1128/JCM.44.5.1873-1874.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Increasing Incidence of Severe Epstein-Barr Virus-Related Infectious Mononucleosis: Surveillance Study

Infectious Diseases and Intensive Care Unit, Pontchaillou University Hospital, Rennes, France,¹ Virology, Pontchaillou University Hospital, Rennes, France²

Received 28 January 2006/ Returned for modification 1 March 2006/ Accepted 2 March 2006

Older patients are more susceptible to severe Epstein-Barr virus (EBV)-related infectious mononucleosis (IM). This condition may increase in industrialized countries where primary EBV infection occurs later in life. Between 1990 and 2004, 38 patients were admitted to our department with EBV-related IM. Two patients died. The annual incidence increased significantly (r = 0.623; P = 0.013).

This article has been cited by other articles:

• Elliott, S. L., Suhrbier, A., Miles, J. J., Lawrence, G., Pye, S. J., Le, T. T., Rosenstengel, A., Nguyen, T., Allworth, A., Burrows, S. R., Cox, J., Pye, D., Moss, D. J., Bharadwaj, M. (2008). Phase I Trial of a CD8+ T-Cell Peptide Epitope-Based Vaccine for Infectious Mononucleosis. J. Virol. 82: 1448-1457 [Abstract] [Full Text]